Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Jiangsu Hengrui Pharma
>>
Phase 4
Welcome,
Profile
Billing
Logout
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
105
210
315
420
525
630
735
840
945
1050
AiTan
(rivoceranib) / HLB Bio Group
AiRuiKa
(camrelizumab) / HLB Bio Group
Irene
(pyrotinib) / Jiangsu Hengrui Pharma
remimazolam tosylate
(HR-7056) / Jiangsu Hengrui Pharma
adebrelimab
(SHR-1316) / Jiangsu Hengrui Pharma
AiRuiYi
(fluzoparib) / Jiangsu Hengrui Pharma
AiRuiKang
(dalpiciclib) / Jiangsu Hengrui Pharma
Hengqu
(hetrombopag) / Jiangsu Hengrui Pharma
Ruiqin
(henagliflozin) / Jiangsu Hengrui Pharma
Itari
(linperlisib) / Shanghai YingLi Pharma
Airui'en
(rezvilutamide) / Jiangsu Hengrui Pharma
Hansoh Xinfu
(flumatinib) / Jiangsu Hengrui Pharma, Jiangsu Hansoh Pharma
Pegylated rhG-CSF
(mecapegfilgrastim) / Jiangsu Hengrui Pharma
Ruizetang
(retagliptin) / Jiangsu Hengrui Pharma
imrecoxib
(BAP 909) / Jiangsu Hengrui Pharma
NovaTears
(perfluorohexyloctane) / Novaliq, Bausch Health, AFT Pharma
Vevye
(cyclosporine ophthalmic solution) / Novaliq, Harrow Health
